Cargando…
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
BACKGROUND: The development of probiotics as therapies to cure or prevent disease lags far behind that of other investigational medications. Rigorously designed phase I clinical trials are nearly non-existent in the field of probiotic research, which is a contributing factor to this disparity. As a...
Autores principales: | Awasthi, Smita, Wilken, Reason, Patel, Forum, German, J. Bruce, Mills, David A., Lebrilla, Carlito B., Kim, Kyoungmi, Freeman, Samara L., Smilowitz, Jennifer T., Armstrong, April W., Maverakis, Emanual |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957407/ https://www.ncbi.nlm.nih.gov/pubmed/27449926 http://dx.doi.org/10.1186/s13063-016-1467-1 |
Ejemplares similares
-
Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants
por: Frese, Steven A., et al.
Publicado: (2017) -
Proteomic Analysis of Bifidobacterium longum subsp. infantis Reveals the Metabolic Insight on Consumption of Prebiotics and Host Glycans
por: Kim, Jae-Han, et al.
Publicado: (2013) -
Phylogenomic disentangling of the Bifidobacterium longum subsp. infantis taxon
por: Tarracchini, Chiara, et al.
Publicado: (2021) -
Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001
por: Karav, Sercan, et al.
Publicado: (2018) -
Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective
por: Blanco, Guillermo, et al.
Publicado: (2020)